Table 2. Results of immunisation efforts among contacts of an imported measles case, by age group, Portugal, 2024 (n = 39).
| Age group | Eligible for immunisation | IVIG < 6 days | Vaccinated < 72h | Vaccinated > 72h | Immunised on time | |
|---|---|---|---|---|---|---|
| n | n | n | n | % | ||
| < 6 months | 5 | 5 | 0 | 0 | 5 | 100 |
| 6–12 months | 3 | 0 | 3 | 0 | 3 | 100 |
| 1–5 years | 14 | 0 | 9 | 3 | 9 | 64.3 |
| 6–18 years | 2 | 1 | 0 | 0 | 1 | 50.0 |
| > 18 years | 15 | 0 | 5 | 5 | 5 | 33.3 |
| Total | 39 | 6 | 17 | 8 | 23 | 59.0 |
IVIG: intravenous human non-specific immunoglobulin.